|
Hemodynamic variables of study patients |
|||
| Baseline |
12 hours |
P value |
|
|
|
|||
| Pulmonary artery occlusion pressure (mmHg) |
1.000 |
||
| Phenylephrine |
15 ± 2 |
17 ± 3* |
|
| Norepinephrine |
15 ± 2 |
17 ± 3* |
|
| Right atrial pressure (mmHg) |
0.902 |
||
| Phenylephrine |
13 ± 3 |
15 ± 3* |
|
| Norepinephrine |
13 ± 3 |
14 ± 3* |
|
| Mean pulmonary arterial pressure (mmHg) |
0.521 |
||
| Phenylephrine |
28 ± 9 |
33 ± 11* |
|
| Norepinephrine |
27 ± 5 |
30 ± 4* |
|
| Pulmonary vascular resistance index (dyne·s/cm5/m2) |
0.330 |
||
| Phenylephrine |
293 ± 253 |
348 ± 296* |
|
| Norepinephrine |
235 ± 103 |
264 ± 105 |
|
| Right ventricular stroke work index (g/m2/beat) |
0.564 |
||
| Phenylephrine |
9 ± 5 |
12 ± 7* |
|
| Norepinephrine |
8 ± 4 |
11 ± 4* |
|
| Left ventricular stroke work index (g/m2/beat) |
0.721 |
||
| Phenylephrine |
25 ± 11 |
35 ± 14* |
|
| Norepinephrine |
25 ± 8 |
37 ± 9* |
|
| Stroke volume index (g/m2/beat) |
0.963 |
||
| Phenylephrine |
45 ± 18 |
49 ± 19 |
|
| Norepinephrine |
46 ± 13 |
50 ± 11 |
|
| Cardiac troponin I (ng/ml) |
0.854 |
||
| Phenylephrine |
1.0 ± 0.9 |
1.1 ± 0.9 |
|
| Norepinephrine |
0.9 ± 0.9 |
1.1 ± 0.8 |
|
|
*P < 0.05 versus baseline (significant time effect). | |||
Morelli et al. Critical Care 2008 12:R143 doi:10.1186/cc7121 |
|||